CD27 and acute myeloid leukemia: reported that CD70/CD27 signaling promotes blast stemness, and blocking CD70/CD27 by mAb could prolong survival in murine AML xenografts, representing that CD70/CD27 is a promising therapeutic strategy for AML (149).